Page 83 - MEMORIA ANUAL 2021
P. 83

   MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
  • Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Carfilzo- mib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd.
63rd Annual Meeting of the American-Society-of-Hematology (ASH). Georgia, Dec 11-14, 2021. Mateos MV, Martínez López J, Rodríguez-Otero P, González-Calle V, González MS, Oriol A, Gutiérrez NC, Ríos R, Rosiñol L, Álvarez MA, Bargay J, González AP, Alegre A, Esca- lante F, Íñigo B, de la Rubia J, Teruel AI, De Arriba F, Palomera L, Hernández MT, López Jiménez J, García Mateo A, Reinoso Segura M, Ocio E, Paiva B, Puig N, Cedena MT, Bladé J, Lahuerta JJ, San-Miguel JF .
• Efficacy and Safety of Eltrombopag Combined with Cyclosporine As First-Line Ther- apy in Adults with Severe Acquired Aplastic Anemia: Results of the Interventional Phase 2 Single-Arm Soar Study.
63rd Annual Meeting of the American-Society-of-Hematology (ASH). Georgia, Dec 11-14, 2021. Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault De Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P .
• Impact of disease treatment on the outcome of patients with Chronic Lymphocytic Leukemia (CLL) with COVID-19: a multicenter study on behalf of GELLC.
16th International Conference on Malignant Lymphomas, Lugano June 18-22, 2021. Muntañola A, Mirás F, Hernández-Rivas JA, Baile M, Osorio S, Terol MJ, Gimeno E, Alon- so R, Baltasar P, López-García A, Labrador J, López-Jiménez J, Hernández-Rodríguez I, Alfayate A, Oliveira AC, Gómez Roncero MI, Vidal MJ, Bárez A, López Rubio M, Riaza R, Correa J, Romero P, Yáñez L, Andreu R, Santiago R, Hernández-Sánchez E, Zabalza A, Torres A, Seri C, Ramírez Payer A, García-Malo MD, García-Pintos M, Mateos Mazón JJ, Rodríguez-Fernández A, Vale AM, Ríos E, Loscertales J, do Nascimiento J, Pérez- Fernández I, Lis MJ, Pérez S, Ruiz ME, Villalón L, Velásquez CA, Campoy F, Muiña B, Soler JA, Sánchez MJ, Cuesta A, Pimentel A, Sánchez M, Ruiz-Camps I, Villacampa G, Bosch F, Abrisqueta P; on behalf of GELLC (Grupo Español de Leucemia Linfática Crónica) .
Grupo cooperativo coautor: GELLC .
• Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and Reverted By IL1β Inhibitors.
63rd Annual Meeting of the American-Society-of-Hematology (ASH). Georgia, Dec 11-14, 2021.
Hurtado-Navarro L, Cuenca EJ, Soler E, Jerez A, Martínez-Banaclocha H, Such E, Bello- sillo B, Zamora L, Hernández-Rivas JM, Marco J, Martínez-Alarcón L, Linares-Latorre MD, Marco J, García Ávila S, Amat P, González T, Martín Izquierdo M, Arnán Sangerman M,
 83
 



















































































   81   82   83   84   85